AI assistant
Sending…
Novartis AG — Director's Dealing 2018
Oct 4, 2018
940_dirs_2018-10-04_7e1344ee-267d-4490-a487-7d3ae61214c7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2018-10-02
Reporting Person: Novartis Bioventures Ltd (10% Owner)
Reporting Person: NOVARTIS AG (10% Owner)
More from Novartis AG
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4
Annual Report
2026
Feb 4
Regulatory Filings
2026
Jan 16
Regulatory Filings
2026
Jan 16
Regulatory Filings
2026
Jan 16
Regulatory Filings
2026
Jan 16